As both SCLY and SEPHS2 play a role in providing selenium from different sources to selenoprotein synthesis, it is possible that either a shift in or redistribution of selenium sources for selenoprotein synthesis occurs in NAFLD livers. The gene discussed is SCLY; the disease is metabolic dysfunction-associated steatotic liver disease.